Ernexa Therapeutics (ERNA) Operating Leases (2019 - 2026)
Ernexa Therapeutics (ERNA) reported Operating Leases of $182,000 for Q2 2026, down 51.6% from $376,000 a year earlier and down 19.5% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Ernexa Therapeutics posted Operating Leases of $277,000, down 41.9% from FY2024.
- Operating Leases has a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
- By year, Operating Leases came in at $477,000 in FY2024 (-98.5%), $32.85 million in FY2023, $887,000 in FY2022 (-61.4%) and $2.3 million in FY2021 (+20.6%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases in data going back to Q1 2019.
- Year over year, Operating Leases has now declined in each of the last eight quarters, with an average decline of 71.2% over the last eight quarters.
- The high point for year-over-year Operating Leases in five years was Q4 2021 (growth of 20.6%); the low point was Q2 2025 (a decline of 99.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $226,000 (Q1 2026), $277,000 (Q4 2025) and $346,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Ernexa Therapeutics | 2.43 Mn | -16.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182,000.00 |
| Mar 31, 2026 | 226,000.00 |
| Dec 31, 2025 | 277,000.00 |
| Sep 30, 2025 | 346,000.00 |
| Jun 30, 2025 | 376,000.00 |
| Mar 31, 2025 | 419,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 36.04 Mn |
| Mar 31, 2024 | 36.57 Mn |
| Dec 31, 2023 | 32.85 Mn |
| Sep 30, 2023 | 35.00 Mn |
| Jun 30, 2023 | 34.96 Mn |
| Mar 31, 2023 | 841,000.00 |
| Dec 31, 2022 | 887,000.00 |
| Sep 30, 2022 | 2.32 Mn |
| Jun 30, 2022 | 2.43 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 2.41 Mn |
API Access
Ernexa Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();